Cargando…

Systematic Review of miRNA as Biomarkers in Alzheimer’s Disease

Currently there are 850,000 people with Alzheimer’s disease in the UK, with an estimated rise to 1.1 million by 2025. Alzheimer’s disease is characterised by the accumulation of amyloid-beta plaques and hyperphosphorylated tau in the brain causing a progressive decline in cognitive impairment. Small...

Descripción completa

Detalles Bibliográficos
Autores principales: Swarbrick, S., Wragg, N., Ghosh, S., Stolzing, Alexandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682547/
https://www.ncbi.nlm.nih.gov/pubmed/30734227
http://dx.doi.org/10.1007/s12035-019-1500-y